Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $9.3 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 49.61.
Market Cap
9.3T
Revenue
4.66T
Profits
187.4B
PE Ratio
49.61
Profit Margin
4.02%
Dividend Yield
0.38%
1058 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.09T | -1.15% | 1,093,420 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 625.09B | -0.93% | 2,790,333 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 442.65B | 1.02% | 2,109,008 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 361.55B | -1.45% | 1,869,106 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 322.16B | -0.26% | 3,497,864 | 66.57B |
| 6 | NVS | Novartis AG | 297.85B | -1.08% | 718,782 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 251.46B | -1.61% | 2,074,660 | 61.37B |
| 8 | AMGN | Amgen Inc. | 223.36B | -0.97% | 901,357 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 223.25B | 0.69% | 1,024,662 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 209.18B | -0.78% | 5,889,028 | 50.34B |
| 11 | ABT | Abbott Laboratories | 190.12B | 1.15% | 3,070,452 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 168.98B | 2.42% | 2,917,005 | 30.46B |
| 13 | PFE | Pfizer Inc. | 151.61B | -1.66% | 23,739,395 | 63.70B |
| 14 | DHR | Danaher Corporation | 146.40B | -0.53% | 1,464,372 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 141.06B | 1.50% | 2,477,943 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 134.46B | 1.25% | 551,453 | 12.59B |
| 17 | SYK | Stryker Corporation | 133.35B | 0.53% | 780,425 | 25.84B |
| 18 | BMY | Bristol-Myers Squibb Company | 130.20B | -1.70% | 5,367,240 | 49.19B |
| 19 | CVS | CVS Health Corporation | 119.28B | -2.52% | 3,815,373 | 412.65B |
| 20 | MDT | Medtronic plc | 115.47B | 0.89% | 3,344,516 | 36.36B |
| 21 | MCK | McKesson Corporation | 104.33B | 1.70% | 486,737 | 410.98B |
| 22 | SNY | Sanofi | 104.24B | 0.16% | 1,899,854 | 55.89B |
| 23 | GSK | GSK plc | 102.63B | -2.09% | 2,040,305 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 89.02B | -0.69% | 638,651 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 84.64B | -1.87% | 469,348 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 80.50B | -0.23% | 334,543 | 15.53B |
| 27 | BSX | Boston Scientific Corporation | 74.37B | 1.70% | 8,606,710 | 21.00B |
| 28 | CI | The Cigna Group | 71.88B | -2.29% | 1,014,569 | 282.38B |
| 29 | COR | Cencora, Inc. | 63.07B | 1.69% | 586,425 | 332.77B |
| 30 | CAH | Cardinal Health, Inc. | 56.14B | 1.07% | 1,973,140 | 254.25B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 56.09B | -0.34% | 1,753,962 | 28.42B |
| 32 | ARGX | argenx SE | 55.41B | -0.62% | 333,039 | 5.32B |
| 33 | EW | Edwards Lifesciences Corporation | 53.85B | 1.52% | 1,653,332 | 6.51B |
| 34 | BDX | Becton, Dickinson and Company | 49.36B | 0.88% | 746,186 | 22.48B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 46.55B | -0.81% | 233,124 | 4.55B |
| 36 | MDLN | Medline Inc. | 46.00B | 3.49% | 4,888,785 | 29.94B |
| 37 | NTRA | Natera, Inc. | 45.61B | -0.60% | 529,038 | 2.71B |
| 38 | HUM | Humana Inc. | 45.00B | -2.85% | 380,368 | 145.68B |
| 39 | RVMD | Revolution Medicines, Inc. | 44.06B | -0.68% | 984,578 | - |
| 40 | HLN | Haleon plc | 43.50B | 0.15% | 6,021,728 | 14.80B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 42.50B | 0.91% | 4,261,957 | 17.32B |
| 42 | A | Agilent Technologies, Inc. | 42.31B | 0.72% | 625,452 | 7.23B |
| 43 | ONC | BeOne Medicines AG | 40.98B | 0.40% | 369,121 | 6.13B |
| 44 | WAT | Waters Corporation | 40.67B | 0.60% | 376,195 | 4.64B |
| 45 | IQV | IQVIA Holdings Inc. | 40.33B | 1.25% | 621,634 | 16.98B |
| 46 | VEEV | Veeva Systems Inc. | 38.52B | 1.04% | 863,986 | 3.32B |
| 47 | ALC | Alcon Inc. | 36.71B | 2.17% | 2,982,948 | 10.86B |
| 48 | DXCM | DexCom, Inc. | 33.65B | 1.73% | 3,631,655 | 4.97B |
| 49 | RPRX | Royalty Pharma plc | 33.48B | 0.45% | 1,382,020 | 2.54B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 32.77B | -0.53% | 1,095,308 | 21.27B |
| 51 | CNC | Centene Corporation | 32.32B | -1.73% | 1,144,830 | 180.30B |
| 52 | RMD | ResMed Inc. | 32.26B | 1.63% | 488,360 | 5.65B |
| 53 | ZTS | Zoetis Inc. | 30.84B | -0.27% | 2,424,753 | 9.53B |
| 54 | BIIB | Biogen Inc. | 30.38B | -0.74% | 427,183 | 10.03B |
| 55 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.31B | 0.94% | 721,685 | 4.80B |
| 56 | ILMN | Illumina, Inc. | 29.09B | 0.43% | 431,388 | 4.49B |
| 57 | INSM | Insmed Incorporated | 28.92B | -1.73% | 1,295,131 | 1.14B |
| 58 | MTD | Mettler-Toledo International Inc. | 28.88B | 0.97% | 60,641 | 4.13B |
| 59 | PHG | Koninklijke Philips N.V. | 26.32B | 0.56% | 919,938 | 20.18B |
| 60 | DGX | Quest Diagnostics Incorporated | 26.28B | 0.21% | 424,203 | 11.56B |
| 61 | LH | Labcorp Holdings Inc. | 26.10B | 0.17% | 250,443 | 14.35B |
| 62 | ROIV | Roivant Sciences Ltd. | 25.51B | -1.29% | 3,422,870 | 7.53M |
| 63 | WST | West Pharmaceutical Services, Inc. | 24.89B | 0.43% | 201,098 | 3.33B |
| 64 | INCY | Incyte Corporation | 24.42B | -0.89% | 551,526 | 5.82B |
| 65 | MRNA | Moderna, Inc. | 23.98B | 0.42% | 4,195,144 | 2.23B |
| 66 | STE | STERIS plc | 23.39B | 0.41% | 263,613 | 6.04B |
| 67 | BNTX | BioNTech SE | 23.30B | -0.05% | 452,370 | 3.03B |
| 68 | UTHR | United Therapeutics Corporation | 22.17B | -2.41% | 148,056 | 3.15B |
| 69 | GH | Guardant Health, Inc. | 22.16B | -1.25% | 605,502 | 1.18B |
| 70 | THC | Tenet Healthcare Corporation | 21.03B | 0.50% | 265,796 | 21.81B |
| 71 | VTRS | Viatris Inc. | 18.70B | - | 5,709,226 | 14.74B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.64B | -0.08% | 1,436,704 | 8.51B |
| 73 | GMAB | Genmab A/S | 18.37B | -0.34% | 1,073,947 | 4.13B |
| 74 | MEDP | Medpace Holdings, Inc. | 16.94B | 0.74% | 100,573 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 16.75B | -0.58% | 244,690 | 998.25M |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 16.48B | -1.70% | 356,600 | 3.37B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 16.31B | -1.44% | 1,975,390 | 713.07M |
| 78 | JAZZ | Jazz Pharmaceuticals plc | 16.08B | -3.44% | 402,200 | 4.60B |
| 79 | COO | The Cooper Companies, Inc. | 15.03B | 0.98% | 787,944 | 4.23B |
| 80 | SOLV | Solventum Corporation | 14.36B | -1.02% | 367,224 | 8.31B |
| 81 | BAX | Baxter International Inc. | 14.35B | -0.07% | 2,596,643 | 11.47B |
| 82 | CRL | Charles River Laboratories International, Inc. | 13.43B | 1.58% | 688,897 | 4.00B |
| 83 | BMRN | BioMarin Pharmaceutical Inc. | 13.40B | 0.51% | 2,180,389 | 3.41B |
| 84 | RVTY | Revvity, Inc. | 12.94B | -0.03% | 818,300 | 2.91B |
| 85 | PEN | Penumbra, Inc. | 12.87B | 0.25% | 117,096 | 1.50B |
| 86 | ICLR | ICON Public Limited Company | 12.87B | 0.44% | 408,132 | 8.29B |
| 87 | FMS | Fresenius Medical Care AG | 12.79B | -1.68% | 596,263 | 22.19B |
| 88 | EXEL | Exelixis, Inc. | 12.76B | -2.78% | 1,108,428 | 2.44B |
| 89 | SNN | Smith & Nephew plc | 12.59B | -0.20% | 650,819 | 6.30B |
| 90 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.50B | 0.20% | 599,295 | 669.50M |
| 91 | ALGN | Align Technology, Inc. | 12.34B | -1.35% | 295,896 | 4.14B |
| 92 | EHC | Encompass Health Corporation | 12.29B | -0.99% | 609,744 | 6.21B |
| 93 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.26B | 3.01% | 281,066 | 1.28B |
| 94 | CORT | Corcept Therapeutics Incorporated | 12.16B | -1.53% | 262,196 | 830.81M |
| 95 | BTSG | BrightSpring Health Services, Inc. | 11.99B | -6.34% | 3,717,839 | 14.37B |
| 96 | HALO | Halozyme Therapeutics, Inc. | 11.80B | 1.28% | 1,641,501 | 1.66B |
| 97 | SMMT | Summit Therapeutics Inc. | 11.79B | -0.61% | 3,706,161 | - |
| 98 | GMED | Globus Medical, Inc. | 11.52B | -0.37% | 1,075,374 | 3.14B |
| 99 | DVA | DaVita Inc. | 11.49B | -1.87% | 562,691 | 14.01B |
| 100 | AXSM | Axsome Therapeutics, Inc. | 11.36B | -1.68% | 516,289 | 776.57M |
| 101 | ELAN | Elanco Animal Health Incorporated | 11.34B | 1.86% | 4,361,323 | 5.02B |
| 102 | TECH | Bio-Techne Corporation | 11.24B | 0.04% | 2,293,618 | 1.21B |
| 103 | ABVX | ABIVAX Société Anonyme | 11.06B | -1.64% | 295,376 | 5.67M |
| 104 | GKOS | Glaukos Corporation | 10.82B | 1.13% | 422,801 | 612.84M |
| 105 | CYTK | Cytokinetics, Incorporated | 10.71B | -0.55% | 670,105 | 67.67M |
| 106 | RDY | Dr. Reddy's Laboratories Limited | 10.52B | 2.30% | 1,445,977 | 3.50B |
| 107 | ENSG | The Ensign Group, Inc. | 10.42B | -1.98% | 125,445 | 5.49B |
| 108 | PRAX | Praxis Precision Medicines, Inc. | 10.25B | - | 202,239 | 7.46M |
| 109 | MOH | Molina Healthcare, Inc. | 10.20B | -1.50% | 152,490 | 42.47B |
| 110 | APGE | Apogee Therapeutics, Inc. | 10.11B | - | 581,416 | - |
| 111 | PODD | Insulet Corporation | 10.03B | 1.27% | 668,567 | 3.05B |
| 112 | TEM | Tempus AI, Inc. | 10.01B | 0.71% | 2,270,883 | 1.43B |
| 113 | HSIC | Henry Schein, Inc. | 9.97B | 1.56% | 389,205 | 13.60B |
| 114 | UHS | Universal Health Services, Inc. | 9.95B | -2.24% | 278,824 | 18.11B |
| 115 | KRYS | Krystal Biotech, Inc. | 9.61B | -2.07% | 83,478 | 440.48M |
| 116 | PTGX | Protagonist Therapeutics, Inc. | 9.59B | -1.19% | 178,429 | 281.99M |
| 117 | BIO | Bio-Rad Laboratories, Inc. | 9.58B | 1.03% | 117,096 | 2.59B |
| 118 | RGEN | Repligen Corporation | 9.42B | 2.35% | 556,506 | 785.10M |
| 119 | AVTR | Avantor, Inc. | 9.29B | 0.07% | 3,859,319 | 6.56B |
| 120 | IONS | Ionis Pharmaceuticals, Inc. | 9.23B | -2.42% | 1,421,872 | 874.09M |
| 121 | SYRE | Spyre Therapeutics, Inc. | 8.98B | -3.26% | 607,878 | - |
| 122 | KYMR | Kymera Therapeutics, Inc. | 8.95B | -0.90% | 2,122,443 | 105.00M |
| 123 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.94B | 0.17% | 1,108,560 | 42.16M |
| 124 | QGEN | Qiagen N.V. | 8.90B | -1.87% | 2,867,695 | 2.10B |
| 125 | HQY | HealthEquity, Inc. | 8.83B | -1.11% | 298,968 | 1.34B |
| 126 | PCVX | Vaxcyte, Inc. | 8.79B | 1.39% | 396,922 | - |
| 127 | BRKR | Bruker Corporation | 8.72B | 1.63% | 967,692 | 3.50B |
| 128 | ATR | AptarGroup, Inc. | 8.58B | 0.98% | 179,215 | 3.93B |
| 129 | OSCR | Oscar Health, Inc. | 8.56B | 0.29% | 3,212,596 | 15.32B |
| 130 | IMVT | Immunovant, Inc. | 8.38B | 1.73% | 764,382 | - |
| 131 | ALKS | Alkermes plc | 8.28B | -0.13% | 669,766 | 1.67B |
| 132 | IBRX | ImmunityBio, Inc. | 8.05B | 1.47% | 3,553,014 | 165.79M |
| 133 | LQDA | Liquidia Corporation | 7.87B | -2.74% | 1,194,954 | 288.07M |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.84B | -1.37% | 389,252 | 239.92M |
| 135 | TWST | Twist Bioscience Corporation | 7.72B | -1.37% | 638,794 | 431.80M |
| 136 | TXG | 10x Genomics, Inc. | 7.69B | 0.73% | 3,178,261 | 616.91M |
| 137 | HIMS | Hims & Hers Health, Inc. | 7.36B | -0.69% | 17,592,301 | 2.58B |
| 138 | HNGE | Hinge Health, Inc. | 7.27B | -1.57% | 967,099 | 720.06M |
| 139 | PACS | PACS Group, Inc. | 7.22B | -5.92% | 415,979 | 5.55B |
| 140 | TGTX | TG Therapeutics, Inc. | 7.08B | 1.55% | 721,976 | 799.54M |
| 141 | CHE | Chemed Corporation | 7.05B | -1.37% | 86,624 | 2.60B |
| 142 | GRFS | Grifols, S.A. | 6.99B | -0.37% | 165,683 | 8.48B |
| 143 | BLTE | Belite Bio, Inc | 6.90B | 4.91% | 186,992 | - |
| 144 | ORKA | Oruka Therapeutics, Inc. | 6.84B | -1.73% | 259,382 | - |
| 145 | CGON | CG Oncology, Inc. | 6.76B | -0.40% | 435,876 | 6.23M |
| 146 | COGT | Cogent Biosciences, Inc. | 6.74B | -6.50% | 1,890,577 | - |
| 147 | CAI | Caris Life Sciences, Inc. | 6.61B | - | 2,830,961 | 989.61M |
| 148 | LNTH | Lantheus Holdings, Inc. | 6.57B | -0.31% | 1,904,874 | 1.56B |
| 149 | MIRM | Mirum Pharmaceuticals, Inc. | 6.42B | 0.24% | 258,351 | 618.07M |
| 150 | ERAS | Erasca, Inc. | 6.40B | 1.77% | 2,225,152 | - |
| 151 | SRRK | Scholar Rock Holding Corporation | 6.34B | 0.37% | 492,498 | - |
| 152 | DNTH | Dianthus Therapeutics, Inc. | 6.11B | -2.25% | 385,362 | 1.90M |
| 153 | PTCT | PTC Therapeutics, Inc. | 6.10B | -2.06% | 422,169 | 1.01B |
| 154 | XENE | Xenon Pharmaceuticals Inc. | 6.09B | -2.04% | 405,721 | 7.50M |
| 155 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.05B | 1.32% | 221,171 | 840.85M |
| 156 | BLCO | Bausch + Lomb Corporation | 6.04B | 0.46% | 100,057 | 5.32B |
| 157 | RDNT | RadNet, Inc. | 6.03B | -0.91% | 427,202 | 2.27B |
| 158 | LGND | Ligand Pharmaceuticals Incorporated | 5.78B | -1.93% | 80,230 | 290.54M |
| 159 | STVN | Stevanato Group S.p.A. | 5.77B | 2.67% | 211,254 | 1.40B |
| 160 | TVTX | Travere Therapeutics, Inc. | 5.72B | -0.36% | 622,040 | 591.33M |
| 161 | TFX | Teleflex Incorporated | 5.67B | 0.62% | 369,837 | 2.25B |
| 162 | DFTX | Definium Therapeutics, Inc. | 5.55B | -8.53% | 2,513,085 | - |
| 163 | MMED | MiniMed Group, Inc. | 5.52B | 0.82% | 486,795 | 3.10B |
| 164 | AMRX | Amneal Pharmaceuticals, Inc. | 5.48B | -3.97% | 1,292,518 | 3.12B |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.48B | 2.22% | 834,324 | 1.58B |
| 166 | SHC | Sotera Health Company | 5.46B | 0.95% | 2,350,663 | 1.22B |
| 167 | CRSP | CRISPR Therapeutics AG | 5.16B | -0.24% | 603,820 | 13.39M |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.08B | 0.27% | 826,271 | 1.14B |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.94B | -0.19% | 696,749 | - |
| 170 | EWTX | Edgewise Therapeutics, Inc. | 4.82B | -0.52% | 604,811 | - |
| 171 | WAY | Waystar Holding Corp. | 4.72B | -0.36% | 1,300,593 | 1.21B |
| 172 | PBLS | Parabilis Medicines, Inc. | 4.65B | 2.27% | 208,926 | - |
| 173 | DOCS | Doximity, Inc. | 4.65B | 1.68% | 4,121,268 | 655.57M |
| 174 | BLLN | BillionToOne, Inc. | 4.61B | -1.06% | 360,393 | 397.41M |
| 175 | INDV | Indivior Pharmaceuticals, Inc. | 4.60B | 1.22% | 1,427,407 | 1.33B |
| 176 | NVST | Envista Holdings Corporation | 4.59B | 1.31% | 1,397,941 | 2.86B |
| 177 | ICUI | ICU Medical, Inc. | 4.57B | 0.11% | 136,217 | 2.16B |
| 178 | MANE | Veradermics, Incorporated | 4.55B | -1.77% | 360,821 | - |
| 179 | LFST | LifeStance Health Group, Inc. | 4.38B | -3.61% | 2,791,894 | 1.58B |
| 180 | RLAY | Relay Therapeutics, Inc. | 4.37B | 0.05% | 1,207,973 | 10.35M |
| 181 | ELVN | Enliven Therapeutics, Inc. | 4.30B | -1.14% | 824,642 | - |
| 182 | LIVN | LivaNova PLC | 4.30B | 2.12% | 280,614 | 1.47B |
| 183 | CELC | Celcuity Inc. | 4.29B | -3.18% | 398,362 | - |
| 184 | CON | Concentra Group Holdings Parent, Inc. | 4.26B | -2.05% | 369,623 | 2.29B |
| 185 | ITGR | Integer Holdings Corporation | 4.25B | - | 585,633 | 1.84B |
| 186 | LEGN | Legend Biotech Corporation | 4.21B | 5.32% | 2,356,892 | 1.27B |
| 187 | ADPT | Adaptive Biotechnologies Corporation | 4.09B | 0.63% | 2,153,543 | 308.08M |
| 188 | TLX | Telix Pharmaceuticals Limited | 4.07B | 1.36% | 47,959 | 803.79M |
| 189 | IRTC | iRhythm Holdings, Inc. | 4.05B | -1.61% | 342,647 | 825.34M |
| 190 | DNLI | Denali Therapeutics Inc. | 4.00B | 0.14% | 523,306 | 3.60M |
| 191 | HAE | Haemonetics Corporation | 4.00B | 1.45% | 303,409 | 1.35B |
| 192 | VKTX | Viking Therapeutics, Inc. | 3.92B | -2.38% | 603,764 | - |
| 193 | TNGX | Tango Therapeutics, Inc. | 3.82B | -4.55% | 1,360,738 | 53.81M |
| 194 | VCYT | Veracyte, Inc. | 3.73B | 0.32% | 323,270 | 561.90M |
| 195 | GPCR | Structure Therapeutics Inc. | 3.71B | -2.87% | 270,616 | - |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.68B | 0.56% | 462,351 | 117.00M |
| 197 | OPCH | Option Care Health, Inc. | 3.63B | -0.98% | 560,878 | 5.69B |
| 198 | OGN | Organon & Co. | 3.58B | 0.18% | 1,444,357 | 6.13B |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.58B | 0.95% | 269,751 | 234.13M |
| 200 | CLDX | Celldex Therapeutics, Inc. | 3.46B | 2.66% | 474,722 | 158.00K |
| 201 | NHC | National HealthCare Corporation | 3.43B | -0.97% | 55,631 | 1.56B |
| 202 | GRAL | GRAIL, Inc. | 3.37B | 0.83% | 330,708 | 165.26M |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.33B | 2.16% | 501,614 | 463.98M |
| 204 | NAMS | NewAmsterdam Pharma Company N.V. | 3.28B | -1.79% | 1,400,579 | 7.12M |
| 205 | ALMS | Alumis Inc. | 3.22B | -8.32% | 1,002,752 | 8.40M |
| 206 | PLSE | Pulse Biosciences, Inc. | 3.18B | 7.30% | 472,557 | 1.19M |
| 207 | MBX | MBX Biosciences, Inc. | 3.17B | -0.45% | 234,405 | - |
| 208 | WRBY | Warby Parker Inc. | 3.16B | -3.10% | 1,183,882 | 911.61M |
| 209 | QURE | uniQure N.V. | 3.11B | -2.69% | 658,384 | 18.67M |
| 210 | IRON | Disc Medicine, Inc. | 3.09B | 2.80% | 136,483 | - |
| 211 | BKD | Brookdale Senior Living Inc. | 3.04B | -6.94% | 10,869,989 | 2.98B |
| 212 | TMDX | TransMedics Group, Inc. | 3.04B | -0.87% | 391,175 | 668.47M |
| 213 | TARS | Tarsus Pharmaceuticals, Inc. | 3.02B | 1.40% | 447,979 | 606.33M |
| 214 | ABCL | AbCellera Biologics Inc. | 3.00B | 4.60% | 14,571,695 | 66.17M |
| 215 | IMNM | Immunome, Inc. | 2.98B | 2.30% | 567,445 | 4.02M |
| 216 | ZLAB | Zai Lab Limited | 2.93B | 10.56% | 1,929,154 | 449.61M |
| 217 | IOVA | Iovance Biotherapeutics, Inc. | 2.91B | 0.39% | 7,677,425 | 324.97M |
| 218 | ACHC | Acadia Healthcare Company, Inc. | 2.89B | -2.17% | 574,111 | 3.37B |
| 219 | PRVA | Privia Health Group, Inc. | 2.81B | -1.79% | 595,112 | 2.36B |
| 220 | SUPN | Supernus Pharmaceuticals, Inc. | 2.80B | 2.36% | 337,326 | 830.44M |
| 221 | ALHC | Alignment Healthcare, Inc. | 2.75B | -3.63% | 2,707,151 | 4.58B |
| 222 | NRIX | Nurix Therapeutics, Inc. | 2.72B | 1.41% | 431,749 | 36.77M |
| 223 | BEAM | Beam Therapeutics Inc. | 2.70B | -0.99% | 756,311 | 156.04M |
| 224 | ATAI | AtaiBeckley Inc. | 2.68B | -0.07% | 2,260,094 | 3.49M |
| 225 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.65B | 5.28% | 3,443,215 | 940.61M |
| 226 | RARE | Ultragenyx Pharmaceutical Inc. | 2.64B | 0.04% | 1,072,181 | 717.00M |
| 227 | ALMR | Alamar Biosciences, Inc. | 2.63B | 35.37% | 1,114,807 | 87.16M |
| 228 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.62B | 3.88% | 382,035 | -665.00K |
| 229 | KOD | Kodiak Sciences Inc. | 2.62B | -3.29% | 294,509 | - |
| 230 | VRDN | Viridian Therapeutics, Inc. | 2.62B | 0.22% | 2,330,434 | 71.13M |
| 231 | AXGN | Axogen, Inc. | 2.61B | 0.85% | 296,625 | 251.17M |
| 232 | HTFL | HeartFlow, Inc. | 2.59B | 2.35% | 292,326 | 191.42M |
| 233 | PBH | Prestige Consumer Healthcare Inc. | 2.54B | 1.08% | 243,452 | 1.10B |
| 234 | NEOG | Neogen Corporation | 2.53B | 1.84% | 773,296 | 870.40M |
| 235 | NKTR | Nektar Therapeutics | 2.53B | -0.07% | 198,383 | 55.63M |
| 236 | BFLY | Butterfly Network, Inc. | 2.52B | -2.37% | 3,566,144 | 112.14M |
| 237 | TRVI | Trevi Therapeutics, Inc. | 2.52B | -0.73% | 837,766 | - |
| 238 | UFPT | UFP Technologies, Inc. | 2.51B | -0.22% | 107,148 | 631.64M |
| 239 | KLRA | Kailera Therapeutics, Inc. | 2.48B | 0.92% | 141,785 | - |
| 240 | GRDN | Guardian Pharmacy Services, Inc. | 2.48B | -5.53% | 426,743 | 1.46B |
| 241 | CDNA | CareDx, Inc. | 2.48B | 1.70% | 284,641 | 458.09M |
| 242 | RGC | Regencell Bioscience Holdings Limited | 2.47B | -5.68% | 172,438 | - |
| 243 | PGEN | Precigen, Inc. | 2.47B | -1.57% | 3,541,239 | 85.72M |
| 244 | WGS | GeneDx Holdings Corp. | 2.47B | 6.16% | 431,678 | 454.43M |
| 245 | PHVS | Pharvaris N.V. | 2.42B | -0.75% | 317,906 | - |
| 246 | COAG | Hemab Therapeutics Holdings, Inc. | 2.41B | 3.50% | 159,025 | - |
| 247 | MLYS | Mineralys Therapeutics, Inc. | 2.39B | -0.95% | 363,623 | - |
| 248 | CLOV | Clover Health Investments, Corp. | 2.35B | -3.28% | 2,817,931 | 2.48B |
| 249 | XRAY | DENTSPLY SIRONA Inc. | 2.34B | 0.51% | 2,192,310 | 3.64B |
| 250 | RAPP | Rapport Therapeutics, Inc. | 2.33B | 3.20% | 294,479 | 20.00M |
| 251 | BHC | Bausch Health Companies Inc. | 2.32B | -2.20% | 880,844 | 10.85B |
| 252 | VCEL | Vericel Corporation | 2.31B | 2.50% | 227,993 | 306.30M |
| 253 | URGN | UroGen Pharma Ltd. | 2.28B | 0.84% | 553,523 | 188.73M |
| 254 | HRMY | Harmony Biosciences Holdings, Inc. | 2.28B | 0.38% | 276,912 | 959.90M |
| 255 | NUVB | Nuvation Bio Inc. | 2.25B | -2.95% | 2,581,680 | 169.90M |
| 256 | PVLA | Palvella Therapeutics, Inc. | 2.24B | 2.02% | 141,153 | - |
| 257 | HCM | HUTCHMED (China) Limited | 2.23B | -0.72% | 10,346 | 549.12M |
| 258 | ESTA | Establishment Labs Holdings Inc. | 2.23B | -0.52% | 201,803 | 245.82M |
| 259 | MESO | Mesoblast Limited | 2.21B | 1.35% | 108,527 | 65.38M |
| 260 | VERA | Vera Therapeutics, Inc. | 2.20B | -3.17% | 987,883 | - |
| 261 | ADMA | ADMA Biologics, Inc. | 2.20B | 0.51% | 1,424,446 | 512.28M |
| 262 | SLS | SELLAS Life Sciences Group, Inc. | 2.17B | 0.18% | 3,103,126 | - |
| 263 | ATRC | AtriCure, Inc. | 2.17B | 2.59% | 260,326 | 569.62M |
| 264 | SEPN | Septerna, Inc. | 2.17B | 19.81% | 754,154 | 98.88M |
| 265 | ADUS | Addus HomeCare Corporation | 2.17B | -0.57% | 92,701 | 1.48B |
| 266 | NEO | NeoGenomics, Inc. | 2.13B | -0.42% | 2,390,591 | 766.30M |
| 267 | BHVN | Biohaven Ltd. | 2.13B | -3.16% | 1,345,941 | - |
| 268 | OCUL | Ocular Therapeutix, Inc. | 2.11B | 3.79% | 1,347,768 | 52.06M |
| 269 | STOK | Stoke Therapeutics, Inc. | 2.10B | 0.81% | 970,463 | 27.59M |
| 270 | MD | Pediatrix Medical Group, Inc. | 2.08B | 0.65% | 301,170 | 1.95B |
| 271 | TSHA | Taysha Gene Therapies, Inc. | 2.07B | 1.49% | 2,497,562 | 7.47M |
| 272 | GHRS | GH Research PLC | 2.05B | 1.22% | 570,530 | - |
| 273 | AUPH | Aurinia Pharmaceuticals Inc. | 2.05B | -0.32% | 419,012 | 311.51M |
| 274 | ZBIO | Zenas BioPharma, Inc. | 2.04B | 1.00% | 812,279 | 10.00M |
| 275 | NVCR | NovoCure Limited | 2.03B | 0.81% | 516,004 | 699.19M |
| 276 | PGNY | Progyny, Inc. | 2.03B | -4.99% | 625,508 | 1.31B |
| 277 | KARD | Kardigan, Inc. | 2.02B | 7.07% | 147,591 | - |
| 278 | AVAH | Aveanna Healthcare Holdings Inc. | 1.96B | -4.81% | 1,344,190 | 2.52B |
| 279 | AGIO | Agios Pharmaceuticals, Inc. | 1.96B | 0.74% | 455,151 | 98.34M |
| 280 | SGRY | Surgery Partners, Inc. | 1.94B | -6.18% | 756,974 | 3.37B |
| 281 | NBTX | Nanobiotix S.A. | 1.90B | 6.36% | 99,804 | 38.27M |
| 282 | LMAT | LeMaitre Vascular, Inc. | 1.88B | 1.33% | 138,961 | 262.43M |
| 283 | SRPT | Sarepta Therapeutics, Inc. | 1.88B | 3.61% | 1,618,655 | 1.97B |
| 284 | FBRX | Forte Biosciences, Inc. | 1.88B | 0.05% | 863,474 | - |
| 285 | SNDA | Sonida Senior Living, Inc. | 1.88B | -5.62% | 516,414 | 481.07M |
| 286 | DMRA | Damora Therapeutics, Inc. | 1.84B | 1.07% | 111,588 | - |
| 287 | GENB | Generate Biomedicines, Inc. | 1.84B | -2.79% | 298,888 | 26.48M |
| 288 | FTRE | Fortrea Holdings Inc. | 1.84B | 1.69% | 499,513 | 2.68B |
| 289 | CMPS | COMPASS Pathways plc | 1.80B | 1.48% | 1,657,041 | - |
| 290 | SNDX | Syndax Pharmaceuticals, Inc. | 1.80B | -1.23% | 562,447 | 252.25M |
| 291 | RXRX | Recursion Pharmaceuticals, Inc. | 1.79B | 1.22% | 8,518,214 | 54.86M |
| 292 | LKFT | Lakefront Biotherapeutics NV | 1.78B | 5.54% | 334,664 | 1.13B |
| 293 | IMCR | Immunocore Holdings plc | 1.76B | 0.77% | 160,785 | 430.78M |
| 294 | PRGO | Perrigo Company plc | 1.76B | 0.32% | 826,830 | 4.14B |
| 295 | TRLV | Trulieve Cannabis Corp. | 1.75B | 0.44% | 437,281 | 1.14B |
| 296 | INSP | Inspire Medical Systems, Inc. | 1.73B | 0.32% | 176,342 | 898.74M |
| 297 | ZYME | Zymeworks Inc. | 1.72B | 0.54% | 263,107 | 37.13M |
| 298 | BLFS | BioLife Solutions, Inc. | 1.72B | 1.33% | 227,096 | 106.69M |
| 299 | AAPG | Ascentage Pharma Group International | 1.71B | -0.72% | 3,053 | 82.08M |
| 300 | ASTH | Astrana Health, Inc. | 1.69B | -8.17% | 327,096 | 3.84B |
| 301 | TRAX | First Tracks Biotherapeutics, Inc. | 1.69B | 1.21% | 321,140 | - |
| 302 | ANAB | AnaptysBio, Inc. | 1.69B | 2.97% | 218,502 | 232.39M |
| 303 | NTLA | Intellia Therapeutics, Inc. | 1.69B | 0.33% | 1,580,990 | 59.51M |
| 304 | OMCL | Omnicell, Inc. | 1.68B | -1.05% | 253,901 | 1.25B |
| 305 | BRVE | Braveheart Bio, Inc. | 1.67B | -5.23% | 432,936 | - |
| 306 | KMTS | Kestra Medical Technologies, Ltd. | 1.65B | -0.85% | 147,226 | 95.13M |
| 307 | TNDM | Tandem Diabetes Care, Inc. | 1.65B | 3.77% | 1,090,088 | 1.04B |
| 308 | XNCR | Xencor, Inc. | 1.63B | 1.85% | 764,243 | 104.97M |
| 309 | ANIP | ANI Pharmaceuticals, Inc. | 1.60B | -1.42% | 258,160 | 978.38M |
| 310 | BCAX | Bicara Therapeutics Inc. | 1.59B | -12.59% | 1,176,405 | - |
| 311 | ABSI | Absci Corporation | 1.57B | 2.77% | 1,457,162 | 1.84M |
| 312 | AVLN | Avalyn Pharma Inc. | 1.56B | 1.97% | 89,443 | - |
| 313 | ARDT | Ardent Health, Inc. | 1.56B | 0.09% | 116,634 | 6.41B |
| 314 | XERS | Xeris Biopharma Holdings, Inc. | 1.53B | 4.76% | 1,154,301 | 335.41M |
| 315 | MAZE | Maze Therapeutics, Inc. | 1.53B | 1.03% | 263,787 | 20.00M |
| 316 | PSNL | Personalis, Inc. | 1.51B | -2.34% | 1,887,170 | 69.67M |
| 317 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.51B | -4.12% | 1,383,880 | 208.78M |
| 318 | VIR | Vir Biotechnology, Inc. | 1.51B | 0.11% | 634,689 | 303.23M |
| 319 | CNMD | CONMED Corporation | 1.50B | 1.33% | 111,451 | 1.37B |
| 320 | INVA | Innoviva, Inc. | 1.49B | 0.05% | 290,971 | 440.00M |
| 321 | TYRA | Tyra Biosciences, Inc. | 1.49B | -4.76% | 342,301 | - |
| 322 | AGL | agilon health, inc. | 1.49B | -8.35% | 280,033 | 5.92B |
| 323 | ATEC | Alphatec Holdings, Inc. | 1.48B | 0.74% | 742,797 | 815.05M |
| 324 | HROW | Harrow, Inc. | 1.47B | -2.95% | 1,474,502 | 275.59M |
| 325 | AZTA | Azenta, Inc. | 1.47B | 0.36% | 356,180 | 613.81M |
| 326 | HCSG | Healthcare Services Group, Inc. | 1.46B | -2.11% | 364,782 | 1.86B |
| 327 | OMDA | Omada Health, Inc. | 1.46B | -4.76% | 1,288,927 | 309.76M |
| 328 | AVBP | ArriVent BioPharma, Inc. | 1.45B | 0.45% | 317,502 | - |
| 329 | ORIC | ORIC Pharmaceuticals, Inc. | 1.43B | 1.17% | 631,441 | - |
| 330 | SDGR | Schrödinger, Inc. | 1.42B | 1.44% | 670,267 | 259.04M |
| 331 | SVRA | Savara Inc. | 1.42B | -2.09% | 612,912 | - |
| 332 | ENOV | Enovis Corporation | 1.42B | 1.69% | 478,859 | 2.30B |
| 333 | JBIO | Jade Biosciences, Inc. | 1.42B | 2.62% | 259,099 | - |
| 334 | INNV | InnovAge Holding Corp. | 1.41B | -4.75% | 107,096 | 949.17M |
| 335 | PAHC | Phibro Animal Health Corporation | 1.39B | 0.59% | 41,759 | 1.50B |
| 336 | MLTX | MoonLake Immunotherapeutics | 1.39B | -6.06% | 2,591,463 | - |
| 337 | AORT | Artivion, Inc. | 1.38B | 7.94% | 404,460 | 471.47M |
| 338 | AKTS | Aktis Oncology, Inc. | 1.37B | 2.49% | 111,810 | 8.28M |
| 339 | ALVO | Alvotech | 1.36B | 1.33% | 515,521 | 562.04M |
| 340 | FRNM | Freenome, Inc. | 1.36B | 3.79% | 841,498 | 34.24M |
| 341 | IART | Integra LifeSciences Holdings Corporation | 1.36B | 2.23% | 316,423 | 1.65B |
| 342 | INBX | Inhibrx Biosciences, Inc. | 1.36B | -0.72% | 99,529 | 1.30M |
| 343 | GLUE | Monte Rosa Therapeutics, Inc. | 1.35B | -0.09% | 318,538 | 28.73M |
| 344 | PNTG | The Pennant Group, Inc. | 1.34B | -3.08% | 112,283 | 1.10B |
| 345 | IMTX | Immatics N.V. | 1.32B | -0.51% | 111,147 | 43.00M |
| 346 | GDRX | GoodRx Holdings, Inc. | 1.32B | 5.74% | 1,346,792 | 785.23M |
| 347 | OBX | Obsidian Therapeutics, Inc. | 1.31B | -13.57% | 64,555 | - |
| 348 | LBRX | LB Pharmaceuticals Inc | 1.31B | -0.74% | 125,743 | - |
| 349 | REPL | Replimune Group, Inc. | 1.30B | 1.32% | 3,324,930 | - |
| 350 | NVAX | Novavax, Inc. | 1.29B | -0.63% | 1,544,059 | 413.80M |
| 351 | DRTS | Alpha Tau Medical Ltd. | 1.28B | 1.91% | 562,876 | - |
| 352 | AMN | AMN Healthcare Services, Inc. | 1.27B | -10.38% | 608,851 | 3.43B |
| 353 | CGEM | Cullinan Therapeutics, Inc. | 1.26B | 7.39% | 524,021 | - |
| 354 | VOR | Vor Biopharma Inc. | 1.26B | -0.51% | 406,648 | - |
| 355 | SPTX | Seaport Therapeutics, Inc. | 1.25B | 1.72% | 68,927 | - |
| 356 | PRCT | PROCEPT BioRobotics Corporation | 1.25B | 0.69% | 616,777 | 337.34M |
| 357 | STAA | STAAR Surgical Company | 1.25B | -0.14% | 465,653 | 290.38M |
| 358 | TDOC | Teladoc Health, Inc. | 1.24B | -3.25% | 1,725,622 | 2.49B |
| 359 | CERT | Certara, Inc. | 1.24B | 0.37% | 1,122,554 | 421.75M |
| 360 | MNKD | MannKind Corporation | 1.23B | -2.29% | 2,598,610 | 393.63M |
| 361 | USPH | U.S. Physical Therapy, Inc. | 1.22B | -0.37% | 93,546 | 804.27M |
| 362 | CRVS | Corvus Pharmaceuticals, Inc. | 1.20B | 3.93% | 471,051 | - |
| 363 | MGTX | MeiraGTx Holdings plc | 1.20B | -0.38% | 127,275 | 79.76M |
| 364 | BVS | Bioventus Inc. | 1.17B | -0.43% | 292,485 | 581.85M |
| 365 | LTGO | Latigo Biotherapeutics, Inc. | 1.17B | -0.54% | 131,392 | - |
| 366 | ETON | Eton Pharmaceuticals, Inc. | 1.16B | -3.32% | 410,051 | 86.93M |
| 367 | IRMD | IRADIMED CORPORATION | 1.15B | -0.49% | 72,070 | 86.34M |
| 368 | AHG | Akso Health Group | 1.14B | -1.48% | 4,326 | 13.83M |
| 369 | IVA | Inventiva S.A. | 1.13B | 0.11% | 234,978 | 7.94M |
| 370 | ANRO | Alto Neuroscience, Inc. | 1.12B | 1.56% | 136,843 | - |
| 371 | CRON | Cronos Group Inc. | 1.11B | 0.83% | 827,433 | 179.09M |
| 372 | NUTX | Nutex Health Inc. | 1.10B | -18.33% | 206,614 | 846.72M |
| 373 | LMRI | Lumexa Imaging Holdings, Inc. | 1.10B | -2.81% | 532,202 | 1.03B |
| 374 | EYPT | EyePoint, Inc. | 1.09B | -3.44% | 1,257,515 | 2.79M |
| 375 | SANA | Sana Biotechnology, Inc. | 1.08B | - | 1,510,262 | - |
| 376 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.07B | 0.21% | 2,268,238 | 41.47M |
| 377 | WVE | Wave Life Sciences Ltd. | 1.05B | -12.19% | 2,347,914 | 65.37M |
| 378 | AVTX | Avalo Therapeutics, Inc. | 1.04B | -1.72% | 518,942 | 59.00K |
| 379 | OPK | OPKO Health, Inc. | 1.04B | 0.36% | 1,195,880 | 587.90M |
| 380 | APMD | Apnimed, Inc. | 1.03B | -7.77% | 116,400 | 120.15M |
| 381 | GERN | Geron Corporation | 1.02B | 7.77% | 6,230,896 | 204.56M |
| 382 | JANX | Janux Therapeutics, Inc. | 1.02B | 1.46% | 304,723 | 24.00M |
| 383 | ODTX | Odyssey Therapeutics, Inc. | 1.01B | -5.23% | 54,685 | 99.00K |
| 384 | CSTL | Castle Biosciences, Inc. | 998.36M | 1.02% | 126,564 | 357.28M |
| 385 | ARDX | Ardelyx, Inc. | 986.78M | -1.00% | 5,778,941 | 450.89M |
| 386 | OMER | Omeros Corporation | 984.30M | -0.15% | 1,254,763 | 9.89M |
| 387 | PCRX | Pacira BioSciences, Inc. | 974.22M | 0.04% | 254,642 | 746.16M |
| 388 | QDEL | QuidelOrtho Corporation | 963.48M | 2.18% | 783,309 | 2.67B |
| 389 | GMRS | GMR Solutions Inc. | 953.52M | -3.00% | 154,223 | 5.83B |
| 390 | SLDB | Solid Biosciences Inc. | 939.29M | 2.34% | 573,934 | - |
| 391 | ABUS | Arbutus Biopharma Corporation | 928.43M | 2.40% | 676,256 | 191.45M |
| 392 | DSGN | Design Therapeutics, Inc. | 910.88M | 1.57% | 191,043 | - |
| 393 | AVR | Anteris Technologies Global Corp. | 905.36M | 3.68% | 333,406 | 1.85M |
| 394 | OLMA | Olema Pharmaceuticals, Inc. | 897.73M | -14.07% | 1,989,681 | - |
| 395 | AURA | Aura Biosciences, Inc. | 895.63M | 5.45% | 715,502 | - |
| 396 | GLAS | Glass House Brands Inc. | 890.10M | -0.85% | 159,513 | 177.68M |
| 397 | TBPH | Theravance Biopharma, Inc. | 878.25M | 0.09% | 387,485 | 104.31M |
| 398 | KURA | Kura Oncology, Inc. | 874.43M | - | 438,140 | 71.64M |
| 399 | INMD | InMode Ltd. | 871.41M | -0.20% | 246,790 | 374.63M |
| 400 | ANNX | Annexon, Inc. | 870.00M | -1.48% | 538,432 | - |
| 401 | AMPH | Amphastar Pharmaceuticals, Inc. | 869.90M | 0.69% | 180,545 | 730.02M |
| 402 | ACRS | Aclaris Therapeutics, Inc. | 869.21M | 0.08% | 573,007 | 8.22M |
| 403 | TALK | Talkspace, Inc. | 868.09M | -0.10% | 1,084,561 | 245.73M |
| 404 | COLL | Collegium Pharmaceutical, Inc. | 867.61M | -2.02% | 760,291 | 808.21M |
| 405 | SIBN | SI-BONE, Inc. | 856.93M | 1.49% | 197,074 | 213.60M |
| 406 | HSTM | HealthStream, Inc. | 848.25M | -1.23% | 96,117 | 321.12M |
| 407 | DBVT | DBV Technologies S.A. | 837.46M | -0.95% | 320,866 | 5.04M |
| 408 | SGP | SpyGlass Pharma, Inc. | 833.86M | -0.91% | 44,106 | - |
| 409 | ATTO | Attovia Therapeutics, Inc. | 828.74M | -2.92% | 313,488 | 1.35M |
| 410 | CBLL | CeriBell, Inc. | 824.86M | 11.81% | 1,162,053 | 101.96M |
| 411 | PHAR | Pharming Group N.V. | 799.42M | 1.94% | 53,698 | 366.48M |
| 412 | CLYM | Climb Bio, Inc. | 797.79M | 2.58% | 464,911 | - |
| 413 | DRUG | Bright Minds Biosciences Inc. | 797.58M | -0.71% | 297,653 | - |
| 414 | OCS | Oculis Holding AG | 784.61M | -0.39% | 90,958 | 1.45M |
| 415 | BBNX | Beta Bionics, Inc. | 784.17M | 6.28% | 366,000 | 119.01M |
| 416 | VREX | Varex Imaging Corporation | 779.53M | 0.19% | 2,752,944 | 865.00M |
| 417 | IMMX | Immix Biopharma, Inc. | 775.84M | 7.06% | 895,446 | - |
| 418 | CADL | Candel Therapeutics, Inc. | 773.07M | 0.49% | 608,616 | - |
| 419 | MNPR | Monopar Therapeutics Inc. | 771.77M | -0.98% | 186,848 | - |
| 420 | RIGL | Rigel Pharmaceuticals, Inc. | 770.54M | -0.98% | 95,207 | 276.79M |
| 421 | PHR | Phreesia, Inc. | 769.56M | 0.08% | 363,754 | 495.59M |
| 422 | FTH | Faeth Therapeutics, Inc. | 764.36M | 3.54% | 121,149 | - |
| 423 | EVO | Evotec SE | 760.14M | 1.92% | 42,610 | 859.03M |
| 424 | SSII | SS Innovations International, Inc. | 756.50M | 0.80% | 5,131 | 48.47M |
| 425 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 747.40M | 0.54% | 128,209 | - |
| 426 | CTMX | CytomX Therapeutics, Inc. | 745.22M | -0.58% | 937,452 | 18.30M |
| 427 | AHCO | AdaptHealth Corp. | 741.75M | 6.51% | 3,137,586 | 3.36B |
| 428 | ALLO | Allogene Therapeutics, Inc. | 733.45M | 1.19% | 3,805,519 | 22.00K |
| 429 | AGMB | AgomAb Therapeutics NV | 729.85M | -1.20% | 42,865 | - |
| 430 | CBIO | Crescent Biopharma, Inc. | 723.98M | -2.39% | 48,536 | 11.88M |
| 431 | GYRE | Gyre Therapeutics, Inc. | 704.06M | -1.19% | 29,744 | 109.82M |
| 432 | ACHV | Achieve Life Sciences, Inc. | 701.16M | 2.40% | 1,572,716 | - |
| 433 | RGNX | REGENXBIO Inc. | 699.08M | 1.63% | 482,151 | 174.48M |
| 434 | SLN | Silence Therapeutics plc | 696.70M | -4.41% | 2,048,279 | 615.00K |
| 435 | NGNE | Neurogene Inc. | 693.85M | -4.73% | 289,428 | 925.00K |
| 436 | IRWD | Ironwood Pharmaceuticals, Inc. | 690.70M | 3.21% | 1,258,658 | 389.32M |
| 437 | PHAT | Phathom Pharmaceuticals, Inc. | 678.33M | -0.35% | 1,275,861 | 239.66M |
| 438 | ZVRA | Zevra Therapeutics, Inc. | 674.60M | -1.05% | 354,056 | 136.07M |
| 439 | ANGO | AngioDynamics, Inc. | 659.25M | 1.27% | 577,003 | 320.17M |
| 440 | SOPH | SOPHiA GENETICS SA | 651.23M | -0.26% | 255,763 | 86.17M |
| 441 | KIDS | OrthoPediatrics Corp. | 639.43M | 5.20% | 150,416 | 252.72M |
| 442 | AUTL | Autolus Therapeutics plc | 633.42M | 14.98% | 5,393,121 | 117.39M |
| 443 | STLN | Starling Oncology, Inc. | 630.86M | 0.49% | 1,344,042 | 587.24M |
| 444 | MDXG | MiMedx Group, Inc. | 629.69M | 1.17% | 628,993 | 355.17M |
| 445 | VSTM | Verastem, Inc. | 627.15M | 1.99% | 1,116,808 | 87.53M |
| 446 | HELP | Cybin Inc. | 625.73M | 0.85% | 697,160 | - |
| 447 | TLRY | Tilray Brands, Inc. | 625.18M | 4.30% | 3,709,583 | 915.45M |
| 448 | NVCT | Nuvectis Pharma, Inc. | 623.94M | 1.46% | 105,605 | - |
| 449 | TECX | Tectonic Therapeutic, Inc. | 622.16M | -2.71% | 97,068 | - |
| 450 | CTKB | Cytek Biosciences, Inc. | 614.82M | 1.50% | 722,478 | 206.71M |
| 451 | BWAY | BrainsWay Ltd. | 605.95M | -2.28% | 80,766 | 56.22M |
| 452 | DCTH | Delcath Systems, Inc. | 599.25M | 3.60% | 906,059 | 95.42M |
| 453 | FDMT | 4D Molecular Therapeutics, Inc. | 595.95M | 2.33% | 229,484 | 88.24M |
| 454 | ARTV | Artiva Biotherapeutics, Inc. | 593.53M | 8.20% | 262,812 | 251.00K |
| 455 | SGMT | Sagimet Biosciences Inc. | 590.66M | -0.05% | 1,236,802 | - |
| 456 | ALT | Altimmune, Inc. | 585.37M | -1.31% | 1,733,555 | 36.00K |
| 457 | ARVN | Arvinas, Inc. | 585.21M | -0.44% | 336,367 | 316.70M |
| 458 | SPRY | ARS Pharmaceuticals, Inc. | 583.90M | -0.51% | 730,485 | 98.99M |
| 459 | CTEV | Claritev Corporation | 582.99M | 0.97% | 84,769 | 994.67M |
| 460 | CRMD | CorMedix Inc. | 571.91M | -3.19% | 642,157 | 400.05M |
| 461 | PRME | Prime Medicine, Inc. | 569.29M | 1.59% | 1,546,494 | 4.07M |
| 462 | PRLD | Prelude Therapeutics Incorporated | 569.28M | 18.84% | 358,166 | 22.42M |
| 463 | AQST | Aquestive Therapeutics, Inc. | 559.58M | 3.96% | 5,194,024 | 50.27M |
| 464 | EIKN | Eikon Therapeutics, Inc. | 558.71M | 6.06% | 300,390 | - |
| 465 | STTK | Shattuck Labs, Inc. | 554.78M | 1.33% | 1,395,165 | 1.00M |
| 466 | CTNM | Contineum Therapeutics, Inc. | 553.78M | 1.59% | 633,746 | - |
| 467 | TCMD | Tactile Systems Technology, Inc. | 544.73M | -17.12% | 1,020,398 | 350.31M |
| 468 | MPLT | MapLight Therapeutics, Inc. | 544.15M | -1.48% | 164,506 | - |
| 469 | VALN | Valneva SE | 542.72M | 5.09% | 77,860 | 180.25M |
| 470 | ZURA | Zura Bio Limited | 542.44M | 1.42% | 1,163,149 | - |
| 471 | EOLS | Evolus, Inc. | 541.61M | 8.32% | 1,751,743 | 316.49M |
| 472 | SRTA | Strata Critical Medical, Inc. | 538.76M | 2.53% | 711,626 | 255.98M |
| 473 | FLGT | Fulgent Genetics, Inc. | 525.95M | 0.29% | 69,948 | 323.93M |
| 474 | CERS | Cerus Corporation | 523.96M | 3.17% | 2,117,099 | 221.55M |
| 475 | EVMN | Evommune, Inc. | 521.52M | 2.13% | 196,257 | 10.00M |
| 476 | NPCE | NeuroPace, Inc. | 520.61M | 2.62% | 156,702 | 99.53M |
| 477 | ASMB | Assembly Biosciences, Inc. | 519.39M | 0.90% | 150,691 | 71.10M |
| 478 | ENTX | Entera Bio Ltd. | 517.69M | -1.64% | 342,761 | 42.00K |
| 479 | ANL | Adlai Nortye Ltd. | 512.40M | -3.17% | 97,860 | 5.00M |
| 480 | BLSM | BlossomHill Therapeutics, Inc. | 512.06M | 4.50% | 143,422 | - |
| 481 | BIOA | BioAge Labs, Inc. | 506.93M | -3.54% | 488,043 | 10.36M |
| 482 | DNA | Ginkgo Bioworks Holdings, Inc. | 505.05M | -1.96% | 845,244 | 132.42M |
| 483 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 484 | OABI | OmniAb, Inc. | 500.14M | 1.47% | 785,260 | 38.46M |
| 485 | KYTX | Kyverna Therapeutics, Inc. | 488.79M | 1.90% | 463,577 | - |
| 486 | RZLT | Rezolute, Inc. | 488.38M | -0.11% | 348,532 | - |
| 487 | PROK | ProKidney Corp. | 483.72M | -5.33% | 2,419,880 | 818.00K |
| 488 | OVID | Ovid Therapeutics Inc. | 482.46M | -1.34% | 585,264 | 7.12M |
| 489 | IKT | Inhibikase Therapeutics, Inc. | 481.72M | 0.20% | 447,871 | 1.00 |
| 490 | RLMD | Relmada Therapeutics, Inc. | 475.21M | -1.87% | 1,623,406 | - |
| 491 | PRTA | Prothena Corporation plc | 472.30M | 0.88% | 289,767 | 54.53M |
| 492 | NRC | NRC Health | 467.17M | 1.05% | 59,143 | 140.00M |
| 493 | BNTC | Benitec Biopharma Inc. | 462.92M | -2.21% | 27,643 | - |
| 494 | OCGN | Ocugen, Inc. | 456.10M | 2.67% | 1,582,278 | 4.58M |
| 495 | SCTX | Scribe Therapeutics Inc. | 455.39M | -3.17% | 28,020 | 36.28M |
| 496 | PBYI | Puma Biotechnology, Inc. | 454.26M | 1.27% | 145,123 | 231.24M |
| 497 | CABA | Cabaletta Bio, Inc. | 454.11M | -0.54% | 2,750,241 | - |
| 498 | LRMR | Larimar Therapeutics, Inc. | 453.54M | 8.35% | 1,103,671 | - |
| 499 | QTTB | Q32 Bio Inc. | 453.09M | -2.87% | 393,816 | 53.74M |
| 500 | EDIT | Editas Medicine, Inc. | 452.29M | 4.80% | 1,438,686 | 47.01M |